Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth - PubMed (original) (raw)
Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth
P N Pharr et al. Proc Natl Acad Sci U S A. 1993.
Abstract
We tested the ability of a constitutively activated erythropoietin receptor [EpoR(R129C)] to alter the growth requirements of primary hematopoietic precursors that terminally differentiate in culture. Two recombinant retroviruses expressing EpoR(R129C), spleen focus-forming virus (SFFVc-EpoR) and myeloproliferative sarcoma virus (MPSVcEpoR), were used to infect fetal liver cells that served as a source of hematopoietic progenitors. Methylcellulose cultures were incubated in the absence of any added growth factors or in combination with selected growth factors. EpoR(R129C) completely abrogated the Epo requirement of erythroid colony-forming units to form erythrocytes after 2-5 days in culture and did not interfere with the differentiation program of these cells. In the absence of added growth factors EpoR(R129C) did not enhance erythroid burst-forming unit development. In contrast to experiments in heterologous cell lines, EpoR(R129C) did not render progenitor cells independent of interleukin 3 or granulocyte/macrophage colony-stimulating factor (GM-CSF). However, when progenitors were cultured with added steel factor, but not with interleukin 3 or GM-CSF, EpoR(R129C) augmented the growth and differentiation of erythroid bursts, mixed erythroid/myeloid, and granulocyte/macrophage (GM) colonies. Furthermore, both viruses were capable of expressing EpoR(R129C) in erythroid, mixed erythroid/myeloid, and GM colonies. Thus an aberrantly expressed and constitutively activated EpoR can stimulate proliferation of some GM progenitors. The ability of EpoR(R129C) to abrogate the Epo requirement of primary hematopoietic cells, but not the requirement for other cytokines, is consistent with the induction of erythroblastosis in vivo.
Similar articles
- Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.
Brugger W, Möcklin W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L. Brugger W, et al. Blood. 1993 May 15;81(10):2579-84. Blood. 1993. PMID: 7683923 - The biology of granulocyte-macrophage colony-stimulating factor: effects on hematopoietic and nonhematopoietic cells.
Baldwin GC. Baldwin GC. Dev Biol. 1992 Jun;151(2):352-67. doi: 10.1016/0012-1606(92)90175-g. Dev Biol. 1992. PMID: 1601172 Review. - Deregulation of erythropoiesis by the Friend spleen focus-forming virus.
Ruscetti SK. Ruscetti SK. Int J Biochem Cell Biol. 1999 Oct;31(10):1089-109. doi: 10.1016/s1357-2725(99)00074-6. Int J Biochem Cell Biol. 1999. PMID: 10582341 Review.
Cited by
- Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of Function.
Zhang H, Means S, Schultz AR, Watanabe-Smith K, Medeiros BC, Bottomly D, Wilmot B, McWeeney SK, Kükenshöner T, Hantschel O, Tyner JW. Zhang H, et al. Cancer Res. 2017 Aug 15;77(16):4258-4267. doi: 10.1158/0008-5472.CAN-17-1052. Epub 2017 Jun 26. Cancer Res. 2017. PMID: 28652245 Free PMC article. - JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
Shi J, Yuan B, Hu W, Lodish H. Shi J, et al. Exp Hematol. 2016 Nov;44(11):1044-1058.e5. doi: 10.1016/j.exphem.2016.07.010. Epub 2016 Jul 26. Exp Hematol. 2016. PMID: 27473563 Free PMC article. - Erythropoietin receptor contributes to melanoma cell survival in vivo.
Kumar SM, Zhang G, Bastian BC, Arcasoy MO, Karande P, Pushparajan A, Acs G, Xu X. Kumar SM, et al. Oncogene. 2012 Mar 29;31(13):1649-60. doi: 10.1038/onc.2011.366. Epub 2011 Aug 22. Oncogene. 2012. PMID: 21860424 Free PMC article. - The erythropoietin receptor: molecular structure and hematopoietic signaling pathways.
Watowich SS. Watowich SS. J Investig Med. 2011 Oct;59(7):1067-72. doi: 10.2310/JIM.0b013e31820fb28c. J Investig Med. 2011. PMID: 21307776 Free PMC article. Review. - Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.
Hardee ME, Cao Y, Fu P, Jiang X, Zhao Y, Rabbani ZN, Vujaskovic Z, Dewhirst MW, Arcasoy MO. Hardee ME, et al. PLoS One. 2007 Jun 20;2(6):e549. doi: 10.1371/journal.pone.0000549. PLoS One. 2007. PMID: 17579721 Free PMC article.
References
- Blood. 1991 May 15;77(10):2142-9 - PubMed
- Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):765-9 - PubMed
- J Cell Physiol. 1991 Sep;148(3):503-9 - PubMed
- Mol Cell Biol. 1991 Oct;11(10):4895-902 - PubMed
- EMBO J. 1991 Dec;10(12):3675-82 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials